Clinical Roundup Kisqali reduced the risk of cancer recurrence while maintaining QOL in phase III study September 15, 2023Vol.49 No.34
Clinical Roundup Nivolumab + ipilimumab more effective in immunotherapy-resistant melanoma than ipilimumab alone September 15, 2023Vol.49 No.34
Clinical Roundup Combination immunotherapy treatment effective before lung cancer surgery, phase II study shows September 15, 2023Vol.49 No.34
Clinical Roundup Enhanced recovery program successfully reduced opioid use after pancreatic cancer surgery September 15, 2023Vol.49 No.34
Clinical Roundup Investigators devise test to identify brain tumors from cerebrospinal fluid September 15, 2023Vol.49 No.34
Clinical Roundup Vitamin C, D supplements led to fewer complications in AML, no OS benefit September 15, 2023Vol.49 No.34
Clinical Roundup Blocking proteins could pull the plug on power for colon tumors September 15, 2023Vol.49 No.34
Clinical Roundup Sylvester researchers help identify mechanisms by which MM escapes targeted immunotherapy September 15, 2023Vol.49 No.34
Clinical Roundup Study suggests immune system plays role in extended PFS in MM September 15, 2023Vol.49 No.34
Clinical Roundup Gene therapy study identifies potential new treatment for liver cancer September 15, 2023Vol.49 No.34
